JP2741339B2 - Method for producing cholesterol-enriched fats and oils - Google Patents
Method for producing cholesterol-enriched fats and oilsInfo
- Publication number
- JP2741339B2 JP2741339B2 JP6011343A JP1134394A JP2741339B2 JP 2741339 B2 JP2741339 B2 JP 2741339B2 JP 6011343 A JP6011343 A JP 6011343A JP 1134394 A JP1134394 A JP 1134394A JP 2741339 B2 JP2741339 B2 JP 2741339B2
- Authority
- JP
- Japan
- Prior art keywords
- cholesterol
- oil
- oils
- fats
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims description 89
- 235000012000 cholesterol Nutrition 0.000 title claims description 45
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000003925 fat Substances 0.000 title description 40
- 239000003921 oil Substances 0.000 title description 39
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 150000004665 fatty acids Chemical class 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 5
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 description 39
- 235000019198 oils Nutrition 0.000 description 38
- 235000020256 human milk Nutrition 0.000 description 13
- 210000004251 human milk Anatomy 0.000 description 13
- 239000000203 mixture Substances 0.000 description 5
- 235000014121 butter Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000020974 cholesterol intake Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、コレステロールを必要
とする人のための油脂に関し、特に乳児用調製乳用のコ
レステロール強化油脂の製造方法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to fats and oils for people in need of cholesterol, and more particularly to a method for producing cholesterol-enriched fats and oils for infant formula.
【0002】[0002]
【従来の技術】近年コレステロールは成人病の原因物質
となるため、食品中から除く努力がされている。しか
し、本来コレステロールは生体に必要不可欠な栄養素で
あり、細胞膜の構成成分として、またホルモンや胆汁酸
の原料として生体内で利用されている。成人の場合、過
剰摂取が生体に対して悪影響を及ぼしているのであり、
適正なレベルのコレステロール摂取は必要である。2. Description of the Related Art In recent years, cholesterol is a causative substance of adult diseases, and efforts have been made to remove it from foods. However, cholesterol is essentially an essential nutrient for living organisms, and is used in vivo as a constituent of cell membranes and as a raw material for hormones and bile acids. In adults, overdose has a negative effect on the body,
Proper levels of cholesterol intake are necessary.
【0003】乳児の場合、神経系の発達が著しいため
に、脳や神経細胞中に多く含まれているコレステロール
の必要性は成人より高いと考えられる。乳児にとっては
母乳が唯一の栄養素補給経路であるため、母乳は大量の
コレステロールを含み、乳児がコレステロールを不足す
ることを防止している。ちなみに、母乳中のコレステロ
ール含有量は通常の場合11.7±1.95mg/10
0mlである(米久保他:小児保健研究、第46巻,第
349〜352頁(1987年))。[0003] In infants, the need for cholesterol, which is high in the brain and nerve cells, is thought to be higher than in adults because of the remarkable development of the nervous system. Because breast milk is the only nutritional pathway for infants, breast milk contains large amounts of cholesterol, preventing the infant from becoming deficient in cholesterol. Incidentally, the cholesterol content in breast milk is usually 11.7 ± 1.95 mg / 10
0 ml (Yonekubo et al .: Children's Health Research, Vol. 46, pp. 349-352 (1987)).
【0004】これに対して従来の乳児用調製乳中には、
5〜8mg/100mlのコレステロールしか含まれて
おらず、その量は母乳の約半分である。乳児用調製乳中
の油脂やタンパクの組成を変えることでコレステロール
含量を少しは高めることはできる。しかし、コレステロ
ール含量を母乳レベルまで高めるにはこれだけでは不十
分である。特開平5−30903号公報にバターセーラ
ムを乳製品に添加する方法が記載されているが、原料に
なるバターセーラムは一般には入手しにくい。油脂に直
接コレステロールを添加する方法はコレステロールの強
化方法として容易であるように思われるが、通常の油脂
はコレステロールの溶解性が低い。[0004] In contrast, in conventional infant formulas,
It contains only 5-8 mg / 100 ml cholesterol, about half the amount of breast milk. The cholesterol content can be increased slightly by changing the composition of the fats and proteins in the infant formula. However, this alone is not enough to raise the cholesterol content to breast milk levels. JP-A-5-30903 describes a method for adding butter serum to dairy products, but butter serum as a raw material is generally difficult to obtain. The method of directly adding cholesterol to fats and oils seems to be an easy method for enhancing cholesterol, but ordinary fats and oils have low cholesterol solubility.
【0005】[0005]
【発明が解決しようとする課題】油脂にコレステロール
を溶解させる際は、約110℃もの高温が必要なため油
脂の劣化が生じる。また、常温における油脂に対するコ
レステロールの溶解度は約2重量%と低く、2重量%以
上の濃度に110℃で溶解できた場合でも室温で放置す
ると析出してしまう。本発明はこれらの問題点を解決
し、油脂の安定性を損なわず、かつ多量のコレステロー
ルを油脂に溶解させる方法を提供するものである。When dissolving cholesterol in fats and oils, a high temperature of about 110 ° C. is required, so that fats and oils deteriorate. Further, the solubility of cholesterol in fats and oils at room temperature is as low as about 2% by weight, and even when the cholesterol can be dissolved at a concentration of 2% by weight or more at 110 ° C., it precipitates when left at room temperature. The present invention solves these problems and provides a method for dissolving a large amount of cholesterol in fats and oils without impairing the stability of fats and oils.
【0006】本発明者らは油脂の脂肪酸組成のコレステ
ロールの溶解度におよぼす影響を調べた結果、炭素数4
〜14の飽和脂肪酸を多く含む油脂が、コレステロール
の溶解度が大きく、さらに、熱に対する安定性が高いこ
とを見い出し、本発明を完成した。すなわち、本発明
は、油脂(a)に脂肪酸成分中炭素数4〜14の飽和脂
肪酸を60重量%以上含む油脂にコレステロールを0.
1重量%〜6重量%添加したコレステロール油脂溶液
(b)を配合することを特徴とするコレステロール強化
油脂の製造方法である。The present inventors have investigated the effect of the fatty acid composition of fats and oils on the solubility of cholesterol, and as a result, have found that the number of
The present inventors have found that fats and oils containing a large amount of saturated fatty acids having a high solubility of cholesterol and having high stability to heat are high. That is, in the present invention, fats and oils containing 60% by weight or more of saturated fatty acids having 4 to 14 carbon atoms in the fatty acid component in fats and oils (a) contain 0.1% of cholesterol.
A method for producing a cholesterol-enriched fat or oil, which comprises blending a cholesterol fat or oil solution (b) added with 1 to 6% by weight.
【0007】コレステロール強化の目的とする油脂とし
ては、棉実油、大豆油、コーン油、パーム油、パーム分
別油、糠油等の植物油脂、魚油、魚硬化油、牛脂、牛脂
分別油、豚脂、豚脂分別油等の動物油脂、中鎖脂肪酸ト
リグリセリド(MCT)等の合成油脂を使用できる。[0007] Fats and oils for the purpose of fortifying cholesterol include vegetable oils such as cottonseed oil, soybean oil, corn oil, palm oil, palm fractionated oil, bran oil, fish oil, fish hardened oil, tallow, tallow fractionated oil, lard fat And animal fats and oils such as fractionated lard oil, and synthetic fats and oils such as medium-chain fatty acid triglyceride (MCT).
【0008】(b)成分のステロール油脂溶液の調整に
用いる炭素数4〜14の脂肪酸を60重量%以上含む油
脂としては、ヤシ油、パーム核油、中鎖脂肪酸トリグリ
セリド(MCT)、トリブチリン等があるが、炭素数4
〜14の脂肪酸を60重量%以上含むものが好ましい。
なお、炭素数4〜14の脂肪酸含量が60重量%未満で
あれば、コレステロールの溶解度が小さくなるために好
ましくない。通常の油脂におけるコレステロールの溶解
度は20℃で約2重量%であり、炭素数4〜14の飽和
脂肪酸を60重量%以上含む油脂では溶解度がその2〜
3倍になる。Examples of fats and oils containing 60% by weight or more of a fatty acid having 4 to 14 carbon atoms used for preparing a sterol fat / oil solution of the component (b) include coconut oil, palm kernel oil, medium-chain fatty acid triglyceride (MCT), tributyrin and the like. There are 4 carbon atoms
Those containing 60 to 14% by weight or more of the fatty acids of No. to No. 14 are preferable.
If the content of the fatty acid having 4 to 14 carbon atoms is less than 60% by weight, the solubility of cholesterol decreases, which is not preferable. The solubility of cholesterol in ordinary fats and oils is about 2% by weight at 20 ° C., and the solubility of fats and oils containing saturated fatty acids having 4 to 14 carbon atoms of 60% by weight or more is 2 to 3% by weight.
It is tripled.
【0009】コレステロールとしては、遊離のコレステ
ロールの他にコレステロールの脂肪酸エステルも使用で
きる。また、カンペステロール、スティグマステロー
ル、β-シトステロール、エルゴステロール、ラノステ
ロール、ラトステロール等の他のステロール類も併用添
加することができる。また、コレステロールは、魚油、
羊毛(ウールグリース)、バターオイル、卵黄油等の天
然物由来のもののほか合成品も使用できる。As cholesterol, fatty acid esters of cholesterol can be used in addition to free cholesterol. In addition, other sterols such as campesterol, stigmasterol, β-sitosterol, ergosterol, lanosterol, and latosterol can also be added together. Also, cholesterol, fish oil,
Synthetic products as well as those derived from natural products such as wool (wool grease), butter oil and egg yolk oil can be used.
【0010】[0010]
【実施例】以下、本発明を参考例、実施例および比較例
により説明する。EXAMPLES The present invention will be described below with reference examples, examples and comparative examples.
【0011】[参考例]魚油由来のコレステロール(日
本化学飼料(株)製:純度94.1%)を精製ヤシ油、
精製パーム核油、MCT(ニッサンパナセート810:
日本油脂(株)製)、精製大豆油、精製パームオレイン
および、精製ヤシ油70重量%と精製大豆油30重量%
との配合油に、それぞれ、2、4および6重量%添加
し、100℃に加熱した後10分間攪拌することにより
溶解させた。なお、表1にこれらの油脂の脂肪酸組成を
示した。また、このコレステロールを溶解させた油脂を
25℃で24時間放置した後の様子を表2に示した。さ
らに、表3に40℃1週間後の臭味および過酸化物価を
示した。なお、表2の24時間放置した後の判定は目視
で行い、表3の風味は官能検査で行なった。Reference Example Cholesterol derived from fish oil (manufactured by Nippon Chemical Feed Co., Ltd .: purity 94.1%) was purified from coconut oil,
Refined palm kernel oil, MCT (Nissan Panathate 810:
Nippon Oil & Fats Co., Ltd.), refined soybean oil, refined palm olein and refined coconut oil 70% by weight and refined soybean oil 30% by weight
2, 4 and 6% by weight, respectively, and heated to 100 ° C., and then dissolved by stirring for 10 minutes. Table 1 shows the fatty acid compositions of these fats and oils. Table 2 shows the state of the fat or oil in which this cholesterol was dissolved at 25 ° C. for 24 hours. Further, Table 3 shows the odor and peroxide value after one week at 40 ° C. In addition, the determination after standing for 24 hours in Table 2 was visually performed, and the flavor in Table 3 was performed by a sensory test.
【0012】[0012]
【表1】 [Table 1]
【0013】[0013]
【表2】 [Table 2]
【0014】[0014]
【表3】 [Table 3]
【0015】以上の結果より、炭素数4〜14の脂肪酸
を60重量%以上含む油脂は、コレステロールの溶解度
が高く、溶解後の風味および保存安定性に優れているこ
とが明らかである。From the above results, it is clear that fats and oils containing fatty acids having 4 to 14 carbon atoms in an amount of 60% by weight or more have high solubility of cholesterol, and are excellent in flavor and storage stability after dissolution.
【0016】[実施例1]母乳脂代替脂として、No.
1〜No.5の5種類の配合油脂を調製し、その内容を
表4に示した。なお、コレステロール油脂溶液としては
参考例と同じものを用いた。これらの配合油脂を、3m
mHg、240〜250℃で3時間脱臭し、コレステロ
ール強化母乳脂代替脂を調製した。これらの母乳脂代替
脂と母乳脂の脂肪酸組成およびコレステロール含量を表
5に示した。[Example 1] No. 1 was used as an alternative fat to mother's milk fat.
1 to No. 5 were prepared, and the contents are shown in Table 4. The same cholesterol oil solution was used as in the Reference Example. 3m of these compounded fats and oils
It was deodorized at mHg and 240 to 250 ° C. for 3 hours to prepare cholesterol-enriched breast milk substitute fat. Table 5 shows the fatty acid composition and cholesterol content of these breast milk substitute fats and breast milk fat.
【0017】[0017]
【表4】 [Table 4]
【0018】[0018]
【表5】 [Table 5]
【0019】表5の母乳脂代替脂はコレステロールを約
0.4重量%含有しており、これを3重量%配合した粉
ミルクを水に溶解して調整粉乳にするとコレステロール
含有量が12mg/100gになり、母乳とほぼ同じレ
ベルである。つぎに、これらの母乳脂代替脂を100m
lの褐色ビンに採取し、窒素ガスシールして40℃の恒
温槽にて保存安定製試験を行った。その結果を表6に示
す。The breast milk substitute fat in Table 5 contains about 0.4% by weight of cholesterol, and when the powdered milk containing 3% by weight of this is dissolved in water to prepare the adjusted powdered milk, the cholesterol content is reduced to 12 mg / 100 g. It is about the same level as breast milk. Next, these mother's milk fat substitute fats
The samples were collected in 1 l brown bottles, sealed with nitrogen gas, and subjected to a storage stability test in a 40 ° C constant temperature bath. Table 6 shows the results.
【0020】[0020]
【表6】 [Table 6]
【0021】表6より、脂肪酸組成中炭素数4〜14の
飽和脂肪酸を60重量%以上含む油脂にコレステロール
を添加したコレステロール油脂溶液を目的の油脂に配合
した母乳脂代替脂No.1〜No.3はNo.4〜N
o.5よりも保存安定性に優れ、風味も良好である。以
上の結果より本発明の方法で製造したコレステロール強
化油脂が母乳脂代替脂としての品質に優れていることが
明らかである。From Table 6, it can be seen that a cholesterol fat / oil solution obtained by adding cholesterol to a fat / oil containing 60% by weight or more of a saturated fatty acid having 4 to 14 carbon atoms in the fatty acid composition was blended with the target fat / oil. 1 to No. No. 3 is No. 4-N
o. 5 is more excellent in storage stability and flavor. From the above results, it is clear that the cholesterol-enriched oil produced by the method of the present invention is excellent in quality as a substitute for mother's milk fat.
Claims (1)
4の飽和脂肪酸を60重量%以上含む油脂にコレステロ
ールを0.1重量%〜6重量%添加したコレステロール
油脂溶液(b)を配合することを特徴とするコレステロ
ール強化油脂の製造方法。1. A method according to claim 1, wherein the fat or oil (a) has 4 to 1 carbon atoms in the fatty acid component.
4. A method for producing a cholesterol-enriched fat or oil, which comprises blending a cholesterol fat or oil solution (b) in which 0.1% to 6% by weight of cholesterol is added to an oil or fat containing saturated fatty acids of 60% by weight or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6011343A JP2741339B2 (en) | 1994-01-07 | 1994-01-07 | Method for producing cholesterol-enriched fats and oils |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6011343A JP2741339B2 (en) | 1994-01-07 | 1994-01-07 | Method for producing cholesterol-enriched fats and oils |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07203848A JPH07203848A (en) | 1995-08-08 |
JP2741339B2 true JP2741339B2 (en) | 1998-04-15 |
Family
ID=11775395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6011343A Expired - Lifetime JP2741339B2 (en) | 1994-01-07 | 1994-01-07 | Method for producing cholesterol-enriched fats and oils |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2741339B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3203485B2 (en) * | 1998-08-19 | 2001-08-27 | 明治乳業株式会社 | Infant food composition with adjusted phospholipid and fatty acid composition |
DE60331428D1 (en) * | 2002-05-20 | 2010-04-08 | Gus Papathanasopoulos | MICROMOLECULAR REFRESHMENT OF CONVENTIONAL OILS FOR LARGE-HEIGHT APPLICATIONS AND IN A LIMITED ROOM |
-
1994
- 1994-01-07 JP JP6011343A patent/JP2741339B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07203848A (en) | 1995-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8221818B2 (en) | Composition with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods | |
DE69906875T2 (en) | Triglycerides and compositions containing them | |
DE69727138T3 (en) | DIETARY BABY FOODS WITH CONJUGATED LINOLEIC ACIDS | |
US4670285A (en) | Infant formula | |
DE60123849T2 (en) | OIL / GREASE COMPOSITION | |
US6174560B1 (en) | Substance for lowering high cholesterol level in serum and methods for preparing and using the same | |
US3865939A (en) | Edible oils having hypocholesterolemic properties | |
JP3195594B2 (en) | A food composition containing a milk-derived phospholipid. | |
EP2879505A1 (en) | New fat blend composition | |
KR20030048466A (en) | Soybean milks containing epa at high concentration and process for producing the same | |
JP2005528435A (en) | Policosanol composition, extraction from new sources, and uses thereof | |
JP2525624B2 (en) | Baby milk powder containing polyunsaturated fatty acids | |
EP0391218B1 (en) | Agent for the atopy prophylaxis | |
JP2001275614A (en) | Oral composition containing phospholipids derived from mammalian milk | |
JP2911526B2 (en) | Oil composition for infant food | |
JP2741339B2 (en) | Method for producing cholesterol-enriched fats and oils | |
JPH03220123A (en) | Appetite supressant and food containing the same suppressant | |
JPWO2003056928A1 (en) | Oil composition for lowering blood lipid | |
JP3187187B2 (en) | Infant formula with breast milk-like lipid composition | |
KR101249082B1 (en) | Infant formula containing hydrolyzed whey powder, hydrolyzed skin milk powder preparation and β-casein | |
WO2002094039A1 (en) | Food or beverage for ameliorating poor protein/energy nutrition | |
JP2968751B2 (en) | Infant formula containing breast milk-like lipid composition | |
JPS6049747A (en) | Phospholipid composition | |
WO1993021774A1 (en) | Method of balancing oils and fats to enhance health | |
JP4190893B2 (en) | Sterol composition, oil and fat composition and food containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090130 Year of fee payment: 11 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090130 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110130 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110130 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 16 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 16 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 16 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 16 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140130 Year of fee payment: 16 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |